Home  >  Products  >  BACE Inhibitor Screening Assay Kit
BACE Inhibitor Screening Assay Kit

BACE Inhibitor Screening Assay Kit

Cat no: 600070


Supplier: Cayman Chemical Company
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
Accumulation of the (beta)-amyloid peptide (A(beta)) in the brain is implicated as the primary cause of neurodegeneration and progression of Alzheimer's disease. BACE is a promising therapeutic target as this protease initiates the first step in A(beta) production. Cayman's BACE Inhibitor Screening Assay Kit provides a convenient method for screening human BACE inhibitors. The assay utilizes a synthetic Swedish mutant APP peptide (EVNLDAEF) that has been linked to a fluorophore (EDANS) at one end and to a quenching agent (Dabcyl) at the other. After cleavage by BACE, the product (peptide-EDANS) is brightly fluorescent with excitation and emission peaks at 335-345 nm and 485-510 nm, respectively.
Catalogue number: 600070
Weight: 0
Form: 96 Well
P type: Assay Kits
Shipping temp: -80
Storage temp: -80
Additional info: Accumulation of the (beta)-amyloid peptide (A(beta)) in the brain is implicated as the primary cause of neurodegeneration and progression of Alzheimer

Get Quote

  • Best Price Guaranteed
  • Quick Response Time
  • Exclusive Promotions
Enquiry_down_arrow
Cayman Chemical Company
Get a Quote Direct from
Cayman Chemical Company

By submitting this form you agree to your details being passed to Cayman Chemical Company for the purpose of generating the best quote*

Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave